2 days 7 hours ago
Diabetes self-management often occurs in social contexts, around others without diabetes. International consensus identifies the pervasive presence of social stigma towards those with diabetes, negatively impacting health, well-being, social and professional lives. We aimed to determine the social experiences of Canadian adults living with type 1(T2D) or type 2 (T2D) diabetes.
Michael Vallis, J.J. Bresolin, Kim Fletcher, Elizabeth Holmes-Truscott, Jane Speight, Laura Syron
6 days 7 hours ago
Denise Montt-Blanchard, Franco Giraudo, Raimundo Sánchez
6 days 7 hours ago
Jamie L. Benham, Nikki Stephenson, Amy Metcalfe, Lois E. Donovan, Denice S. Feig, Christy Pylylpjuk, Chelsea Ruth, Howard Berger, Sarah M. Sigurdson, Baiju R. Shah, Jennifer M. Yamamoto
1 week ago
Diabetes care in Canada is compromised by the lack of resources to adequately address the mental health challenges associated with both type 1 and type 2 diabetes. To address this gap Breakthrough T1D (formerly JDRF) Canada and Diabetes Canada developed a bilingual training program, and associated directory listing successful graduates, to educate and empower existing mental health providers to better provide services to those living with diabetes. This paper reports on the development and initial outcomes of this virtual training program.
T.S. TANG, J.C. KICHLER, Z.R. ANDERS, M. RAFFRAY, T.R. SHEPHERD, B.A. WICKLOW, J. BANNISTER, M. GUPTA, A.M. HAILMAN, G.M. KLEIN, J. LEWIS, L.I.N.K.L.A.T.E.R. S E, S.D. MANKIKAR, C. POPE, K.D. RYAN, R. RABASA-LHORET, C. TOURIGNY, M. VALLIS
3 weeks ago
Michael Vallis, Lori Berard, Emmanuel Cosson, Finn Boerlum Kristensen, Fleur Levrat-Guillen, Nicolas Naiditch, Remi Rabasa-Lhoret, William Polonsky
3 weeks ago
Kagan E. Karakus, Halis K. Akturk
3 weeks 6 days ago
Immune-Inflammation plays a crucial role in the pathogenesis of diabetic kidney disease (DKD), but the exact assessment of indicators are undefined. Our paper examined the link between Systemic immune-inflammation index (SII) and mortality risk in DKD, and explore the effect of sex disparities on it.
Yun She, Xiangyun Guo, Ying Tan, Qingqing Liu, Lingling Zhu, Xiqiao Zhou, Jiangyi Yu, Qianhua Yan
1 month ago
Patient decision aids (PtDAs) are evidence-based interventions to help people faced with difficult healthcare decisions. Little is known about their effectiveness in people facing diabetes related decisions.
Sandhya Goge, Christopher Tran, Krystina B. Lewis, Meg Carley, Carol Bennett, Dawn Stacey
1 month ago
Tricia M. Peters, Anne-Sophie Brazeau, Lia Bally, Alexa Govette, Elsa Heyman, Mary E. Jung, Céline I. Laesser, Élodie Lespagnol, Jessica E. Logan, Zeinab Momeni, Tawnya Perry, Meryem K. Talbo, Anne Bonhoure, Jenna A.P. Sim, Jasmin von Zezschwitz, Dessi P…
1 month ago
Regular physical activity is a key, patient-centred therapy for people with diabetes to manage their glycaemia. The International Working Group on the Diabetic Foot (IWGDF) recommends optimisation of glycaemic control for people with/at risk of diabetes-related foot ulcer (DFU), however people with DFU are commonly instructed by clinicians to avoid physical activity so as not to worsen the ulcer. The effects of exercise on glycaemia, fitness, and wound healing in people with active DFU are not clear.
Callum J. Baker, Vivienne Chuter, Magali Brousseau-Foley, Danqing Min, Angela Searle, Stephen M. Twigg, Nathan A. Johnson
1 month 1 week ago
Population studies have identified common genetic variants contributing substantially to the burden of diabetes in Greenland. However, handling of suspected monogenic diabetes in diabetes clinics in Greenland has not been described. We aimed to describe the referral rate, prevalence, and genetic causes of clinically identified monogenic diabetes in Greenland.
Anne Cathrine Baun Thuesen, Marie Balslev Backe, Genís Garcia-Erill, Mikkel Schubert, Kristian Ebbesen Hanghøj, Ida Moltke, Anders Albrechtsen, Niels Grarup, Anette Prior Gjesing, Marit Eika Jørgensen, Torben Hansen, Michael Lynge Pedersen
1 month 4 weeks ago
Attainment of the glycated hemoglobin (A1C) target of ≤7.0% is consistently low among those living with type 1 diabetes (T1D). We evaluated endocrinologists’ acceptability and implementation of A1C targets.
Sanchit Kaushal, Patience Fakembe, Ilana J. Halperin, Gillian A. Hawker, Alanna Weisman
1 month 4 weeks ago
I am writing in response to the study by Vallis et al in a recent issue of the Journal [1]. The authors present a convincing case for the importance of self-management in type 2 diabetes (T2D). Their study introduces the Impact of Glucose Monitoring on Self-Management Scale to measure engagement in self-management behaviours facilitated by continuous glucose monitoring (CGM) technologies.
Saad Khan, Fatima Naveed, Ayesha Khan, Rizwan Ahmad, Faraz Arshad
2 months 2 weeks ago
Our aim in this study was to describe a type 1 diabetes mellitus (T1DM) transition care model by assessing clinic attendance, glycemic management, and diabetes-related hospitalizations.
Samantha Jacobson, Isabella Albanese, Jonathan-Raphaël Stetco, Natasha Garfield
2 months 2 weeks ago
Cystic fibrosis (CF) is a genetic disorder that primarily affects the lungs and digestive system. Cystic fibrosis transmembrane conductance regulator (CFTR) modulators, such as elexacaftor-tezacaftor-ivacaftor (ETI), improve the function of the defective CFTR protein and have significantly improved the management of CF by enhancing lung function.
Mirna Gerges, Meredith Chiasson, Carly Nichols, Nancy Morrison, Barna De
2 months 2 weeks ago
Diabetes duration is an underappreciated risk factor in type 2 diabetes (T2DM) management that can increase the risk of complications and potentially decrease the effectiveness of lifestyle interventions. However, it is unclear whether T2DM duration impacts the efficacy of an elastic band resistance training intervention for older adults living with comorbid T2DM and frailty. In this analysis we aimed to investigate and better understand the impact of a 16-week elastic band resistance training and diabetes education intervention on physical functioning, glycemia, and frailty in older adults of different T2DM durations.
Amy M. Thomson, Isaac C. Cull, Logan E. Peskett, Danielle R. Bouchard, Martin Sénéchal
2 months 2 weeks ago
There has been substantial technological and medical advancement in the management of type 1 diabetes (T1D) in recent decades. Vital exogenous insulin can be delivered to people living with T1D (PwT1D) using automated insulin delivery (AID) systems containing an algorithm that automatically adjusts subcutaneous insulin infusion based on glucose data from a continuous glucose monitor (CGM) [1]. For most PwT1D, the goal is to increase the glucose time in optimal range (TIR%: 3.9 to 10.0 mmol/L [70 to 180 mg/dL]) to reduce risk of hypoglycemia, hyperglycemia, and their consequences [2].
Maha Lebbar, Anne Bonhoure, Rémi Rabasa-Lhoret, Zekai Wu
3 months 1 week ago
The publisher regrets that this article has been temporarily removed. A replacement will appear as soon as possible in which the reason for the removal of the article will be specified, or the article will be reinstated.The full Elsevier Policy on Article Withdrawal can be found at https://www.elsevier.com/about/policies/article-withdrawal.
Jill Trinacty, Ronald M. Goldenberg
3 months 1 week ago
3 months 1 week ago
Checked
41 minutes 27 seconds ago
Canadian Journal of Diabetes RSS feed.
Subscribe to Canadian Journal of Diabetes feed
